Analysis on key parameters in subretinal injection facilitating a predictable and automated robot‐assisted treatment in gene therapy

Author:

Huang Ching‐Wen1,Yang Hung‐Yu2,Chen Ta‐Ching13,Chen Cheng‐Wei2ORCID

Affiliation:

1. Department of Ophthalmology National Taiwan University Hospital Taipei Taiwan

2. Department of Electrical Engineering National Taiwan University Taipei Taiwan

3. Center of Frontier Medicine National Taiwan University Hospital Taipei Taiwan

Abstract

AbstractBackgroundSubretinal injection (SRI) has become an important surgical method for treating vitreoretinal diseases. Nevertheless, the optimisation of bleb formation in SRI, for the attainment of desired therapeutic outcomes, still requires further investigation.MethodsThis study analysed the influence of surgical parameters on SRI using a robotic setup. The surgical procedure was automated using visual guidance. A predictive model for bleb formation was established through regression analysis. To validate the model, we compared the clinical data's target area with the simulated SRI's actual area using parameters determined by the predictive model.ResultsThe insertion angle dominated the eccentricity and area of the bleb. The injection speed dominated the axial angle. Automated SRI increased success rate and produced predictable outcomes.ConclusionsWe could provide accurate SRI on phantom models by adjusting surgical parameters based on the patient's clinical information. Automatic robot‐assisted SRI is a promising surgical technique with highly predictable results.

Funder

National Science and Technology Council

Publisher

Wiley

Subject

Computer Science Applications,Biophysics,Surgery

Reference27 articles.

1. Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases

2. RGX‐314 gene therapy pharmacodynamic study for neovascular age‐related macular degeneration (nAMD).https://ClinicalTrials.gov/show/NCT04832724

3. FocuS.First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects with Dry AMD.https://ClinicalTrials.gov/show/NCT03846193

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3